JT

Jing Ting Teo

Regulatory Affairs Director at Miltenyi Biomedicine

Jing Ting Teo currently serves as the Regulatory Affairs Director at Miltenyi Biomedicine, following a previous role in the same position at Everest Medicines. With extensive experience in regulatory affairs, Jing Ting Teo has held leadership roles at Sanofi Genzyme, where responsibilities included overseeing international oncology regulatory strategies and managing submissions across multiple regions. Prior positions include roles at Novartis and Pfizer, where Jing Ting Teo managed regulatory projects and product registrations. Educational credentials include a degree from the National University of Singapore.

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Miltenyi Biomedicine

2 followers

Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients with unmet medical needs worldwide. We work in partnership with physicians and other healthcare providers to expand access to new therapies. Our clinical research program includes: CAR T, CAR NK, our proprietary Adapter CAR™ and induced pluripotent stem cells (iPSC) technologies. For more information, please visit our website at www.miltenyibiomedicine.com.